Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Auerswald

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Pediatrics|January 29, 2000
Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)J Klinge, K Auberger, G Auerswald, et al.
Lancet (London, England)|February 13, 1993
Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand diseaseW Kreuz, D Klarmann, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 25, 2016
Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgeryM A Escobar, G Auerswald, S Austin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2015
The EPIC study: a lesson to learnG Auerswald, K Kurnik, L M Aledort, et al.
Thrombosis and Haemostasis|September 1, 1993
A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healingY Wada, K Niwa, H Maekawa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2011
When should prophylaxis therapy in inhibitor patients be considered?G Young, G Auerswald, V Jimenez-Yuste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2006
Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 geneF H Herrmann, G Auerswald, A Ruiz-Saez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 3, 2004
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia AA Villar, S Aronis, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in GermanyG Auerswald, M von Depka Prondzinski, B Ehlken, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIIIW Kreuz, S Becker, E Lenz, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Pediatrics|January 29, 2000
Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)J Klinge, K Auberger, G Auerswald, et al.
Lancet (London, England)|February 13, 1993
Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand diseaseW Kreuz, D Klarmann, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 25, 2016
Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgeryM A Escobar, G Auerswald, S Austin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2015
The EPIC study: a lesson to learnG Auerswald, K Kurnik, L M Aledort, et al.
Thrombosis and Haemostasis|September 1, 1993
A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healingY Wada, K Niwa, H Maekawa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2011
When should prophylaxis therapy in inhibitor patients be considered?G Young, G Auerswald, V Jimenez-Yuste, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2006
Factor X deficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 geneF H Herrmann, G Auerswald, A Ruiz-Saez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 3, 2004
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia AA Villar, S Aronis, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in GermanyG Auerswald, M von Depka Prondzinski, B Ehlken, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1995
Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIIIW Kreuz, S Becker, E Lenz, et al.
Pageof 5